The largest database of trusted experimental protocols

Red blood lysis buffer

Manufactured by BioLegend
Sourced in United States

Red Blood Lysis buffer is a laboratory reagent designed to selectively lyse or disrupt red blood cells in a sample, while leaving other cell types intact. It is commonly used in various cell isolation and analysis protocols to remove erythrocytes and enrich the sample with the desired cell population.

Automatically generated - may contain errors

4 protocols using red blood lysis buffer

1

Cardiomyocyte Isolation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight weeks after the 5/6Nx operation, the heart was exposed and perfused with 10 mL of PBS from the left ventricle. After removing the atria, the ventricles were digested in PBS containing 500 μg/mL of collagenase type II (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan), 200 μg/mL of CaCl2 (Nacalai Tesque, Kyoto, Japan), 0.05% trypsin (Sigma-Aldrich), and 10% FBS at 37 °C for 10 min with agitation. Digested samples were further dissociated by passing them through a 23-gauge needle three times. After treating with Red Blood Lysis buffer (BioLegend, CA, USA), isolated cells were filtered through a 40 μm strainer.
+ Open protocol
+ Expand
2

Adipose Tissue and Blood Collection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Visceral adipose tissue (VAT) was collected from OB-ND, OB-Dys and LC during surgery. In particular, omental fat was collected from obese patients and perirenal fat from LC. Blood was withdrawn before general anesthetic injection. VAT was transferred to the laboratory in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with GlutaMAX (ThermoFisher – Scientific), bovine serum albumin (BSA), penicillin/streptomycin (P/S), and HEPES, where it was processed within 90 min from the collection. VAT was finely minced and digested with collagenase IV (Sigma-Aldrich) resuspended in PBS with a final concentration of 2 mg/mL for 40 min at 37°. The sample was then washed with DMEM high glucose (10% FBS, 1% P/S, 1% Glutamine) and treated with Red Blood Lysis buffer (Biolegend) to obtain the stromal vascular fraction (SVF). After washing, the pellet of SVF was filtered and counted. Whole blood (WB) was collected simultaneously with VAT and used for flow cytometry analysis. Peripheral blood mononuclear cells (PBMCs) were obtained using Lympholyte Cell Separation density gradient centrifugation media (Cedarlane). After centrifugation, the PBMC ring was collected and washed two times with PBS.
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
After sacrifice, spleen and lung samples were mashed through 70 µm strainer (22363548, Fischer scientific) to a new well. The strainer was washed with MAC buffer (2mM EDTA, 0,5% BSA, 1 x PBS). Isolated cells were incubated for 5 min RT with red blood lysis buffer (420301, Biolegend). The reaction was stopped with 1 x PBS. 1 x 106 cells were spined down (5 min, 500 x G) and resuspend in 2% BSA, 1 x PBS, 2 µL TruStain FcX (101320, Biolegend). Total cellular fraction isolated from lungs were analyzed from the presence of lymphocytes. Specifically, the isolated cells were incubated with anti-CD8 and anti-CD19 antibodies according to manufacturer’s recommendations (Table S2). Isolated spleen cells were incubated with conjugated CD19/CD3 antibodies (Table S2) for 1 h at 4°C in dark. Blood was drawn with intracardiac punctures into anti-coagulated K2E tubes (BD Microtainer, 1307939). Whole blood was stained with conjugated anti-CD19 antibody for 1 h at 4°C in dark (Table S2). All samples were washed with cell staining buffer (BioLegend, 420201) and centrifugated for 5 min at 500 g. Cell pellet was resuspended in 500 µL of cell staining buffer. The presence of CD19-positive cells was analyzed using flow cytometry (BD LSRFortessa, BD Biosciences). The data was analyzed with Flowing Software 2.5.1 (Turku, Finland).
+ Open protocol
+ Expand
4

Blood Cell Lysis and Cryopreservation

Check if the same lab product or an alternative is used in the 5 most similar protocols
From each individual, 100 µL of blood was treated with red blood lysis buffer (Biolegend, San Diego, CA, USA) according to manufacturer’s instruction to eliminate red blood cells. Red blood cell-depleted immune cells were then fixed and permeabilized using a Fixation/Permeabilization kit (Thermo Fisher Scientific, Grand Island, NE, USA) according to the manufacturer’s protocol. After permeabilization, cells were washed and placed in 200–250 µL freezing medium containing 90% FCS and 10% dimethyl sulfoxide and stored at −80 °C. Frozen samples were then shipped in liquid nitrogen to Germany for flow cytometry analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!